DOES MCA CONTRIBUTE TO THE FOLLOW-UP OF BREAST-CANCER PATIENTS BY CA-15-3

  • Authors:
    • E FENIG
    • J NORDENBERG
    • D REGEV
    • H LURIE
    • A SULKES
  • View Affiliations

  • Published online on: October 1, 1992     https://doi.org/10.3892/ijo.1.5.547
  • Pages: 547-549
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Mucin-like carcinoma-associated antigen (MCA) and CA 15-3 tumor markers were randomly assayed in 234 consecutive breast cancer patients. It was found that 45 patients (19.2%) had elevated MCA levels (cut-off level >14 U/ml) and normal CA 15-3 levels (cut off level >30 U/ml). In 14 of these 45 patients (31.1%), overt metastases were detected, although five had started their follow-up with no evidence of disease. In these five patients, the median lead time was nine months. In our limited experience, it was found that measuring MCA levels in the serum in the presence of normal CA15-3 levels contributes to early detection and monitoring of recurrences in follow-up of breast cancer patients.

Related Articles

Journal Cover

October 1992
Volume 1 Issue 5

Print ISSN: 1019-6439
Online ISSN:1791-2423

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
FENIG E, NORDENBERG J, REGEV D, LURIE H and SULKES A: DOES MCA CONTRIBUTE TO THE FOLLOW-UP OF BREAST-CANCER PATIENTS BY CA-15-3. Int J Oncol 1: 547-549, 1992.
APA
FENIG, E., NORDENBERG, J., REGEV, D., LURIE, H., & SULKES, A. (1992). DOES MCA CONTRIBUTE TO THE FOLLOW-UP OF BREAST-CANCER PATIENTS BY CA-15-3. International Journal of Oncology, 1, 547-549. https://doi.org/10.3892/ijo.1.5.547
MLA
FENIG, E., NORDENBERG, J., REGEV, D., LURIE, H., SULKES, A."DOES MCA CONTRIBUTE TO THE FOLLOW-UP OF BREAST-CANCER PATIENTS BY CA-15-3". International Journal of Oncology 1.5 (1992): 547-549.
Chicago
FENIG, E., NORDENBERG, J., REGEV, D., LURIE, H., SULKES, A."DOES MCA CONTRIBUTE TO THE FOLLOW-UP OF BREAST-CANCER PATIENTS BY CA-15-3". International Journal of Oncology 1, no. 5 (1992): 547-549. https://doi.org/10.3892/ijo.1.5.547